Sanofi Faces Texas Lawsuit Alleging Illegal Payments to Influence Drug Prescriptions sheeba farhat21 Feb 2026 11:00 AM ISTNew Delhi: Texas Attorney General Ken Paxton on Thursday sued Sanofi for allegedly "bribing" providers to prescribe its medications over...
Ixekizumab and tirzepatide combo Improves Skin Clearance and Weight Loss in Psoriasis Patients with Obesity: Study Dr. Kamal Kant Kohli19 Feb 2026 8:45 AM ISTNew findings indicate that in adults with moderate-to-severe plaque psoriasis who are overweight or obese, combined treatment with ixekizumab (Taltz)...
Eli Lilly Announces USD 3.5 Billion US Manufacturing Facility for Next-Gen Obesity Drugs sheeba farhat31 Jan 2026 5:27 PM ISTNew Delhi: Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in an effort...
Roche's Experimental Obesity Drug Delivers Up to 22.5% Weight Loss in Phase-II Trial sheeba farhat28 Jan 2026 4:46 PM ISTRoche's experimental obesity drug CT-388 reduces appetite and is in the same class as Lilly's market-leading Zepbound, also known as tirzepatide and...
No Link to Suicidal Thoughts: USFDA Seeks Label Change for Popular Weight-Loss Drugs Wegovy, Zepbound sheeba farhat14 Jan 2026 6:57 PM ISTThe warnings, part of their original approval, were based on reports of such events observed with a variety of older medicines used or studied for...
Ixekizumab and Tirzepatide combo Improves PsA Control and Weight Loss, suggests study Dr. Kamal Kant Kohli13 Jan 2026 8:15 PM ISTThe TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis disease control and greater...
Medical Bulletin 10/January/2026 Anshika Mishra10 Jan 2026 3:00 PM ISTHere are the top medical news for today:Review suggests most GLP-1 users regain weight within two years after stopping Weight loss drugs work wonders...
Review suggests most GLP-1 users regain weight within two years after stopping Anshika Mishra10 Jan 2026 8:00 AM ISTWeight loss drugs work wonders for shedding pounds, but stopping them can bring the weight back faster than ever. A new University of Oxford review...
Eli Lilly Expands Immunology Pipeline with USD 1.2 Billion Ventyx Buyout sheeba farhat9 Jan 2026 2:53 PM ISTThis is Lilly's first major transaction of 2026, following a year when its market value topped USD 1 trillion on surging sales of GLP-1 drugs...
Eli Lilly, Nimbus Tie Up in USD 1.35 Billion AI-Driven Pact to Develop Oral Obesity Drugs sheeba farhat7 Jan 2026 4:11 PM ISTNimbus will use its AI to help identify drug candidates, while Lilly will contribute its metabolic-disease expertise to develop an easy-to-take oral...
Tirzepatide may only temporarily suppress brain activity involved in "food noise", suggests study Dr. Kamal Kant Kohli24 Nov 2025 9:00 PM ISTA rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, ...
Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom Ruchika Sharma22 Nov 2025 5:49 PM ISTBengaluru: Eli Lilly just hit a USD 1 trillion in market value, becoming the first-ever pharmaceutical company to join the exclusive...
